6 First Eagle Investments United Therapeutics Trades
First Eagle Investments started to build up the position in United Therapeutics in Q3 2014 and continued to invest until Q3 2015. Since then they sold 549 Thousand shares. The investor sold all their shares in Q4 2015 and doesn't own any shares in United Therapeutics anymore.
Avg closing price
Price range
Sold -549 Thousand shares
Q4 2015
Avg closing price
$145.57
Price range
$119.57
-
$160.91
Increased shares by 28.6% (+122 Thousand shares)
Q3 2015
Avg closing price
$160.39
Price range
$131.24
-
$179.15
Increased shares by 14.6% (+54.3 Thousand shares)
Q2 2015
Avg closing price
$179.89
Price range
$159.69
-
$188.56
Increased shares by 3.4% (+12.4 Thousand shares)
Q1 2015
Avg closing price
$152.45
Price range
$124.93
-
$179.51
Increased shares by 37.4% (+98.1 Thousand shares)
Q4 2014
Avg closing price
$128.85
Price range
$122.11
-
$134.80
New holding (+262 Thousand shares)
Q3 2014
Avg closing price
$103.32
Price range
$86.44
-
$136.16
News about United Therapeutics Corp and First Eagle Investments
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Harel Insurance Investments & Financial Services Ltd.
Harel Insurance Investments & Financial Services Ltd. trimmed its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 36.8% during the ...
United Therapeutics Co. (NASDAQ:UTHR) Stake Lowered by New York Life Investments Alternatives
New York Life Investments Alternatives reduced its stake in shares of United Therapeutics Co. (NASDAQ:UTHR) by 25.4% during the 2nd quarter, according to the...